Lapinig, Anthony T.

HRN: 22 07 81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/14/2022
11/21/2022
IV
4.5
Q6h
Pelvic Abscess
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: